Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin Interaction and Self-Administration in Cocaine Use Disorder
NCT02537873Phase 1Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Jul 2015
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cocaine use disorder (CUD) comparing Lorcaserin with Placebo (2 arms). Primary endpoints: Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability) - Heart Rate at Day 12, Cocaine Self-administration Choice Selection at 13 days and 4 more. Started Jul 2015; status: completed.
02
Drugs
lorcaserin
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02537873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537873.